Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA strange or altered taste in the mouth is one of the less-talked-about effects reported by people using tirzepatide. It is real, it has a biological basis, and for most people it settles as the body adjusts to treatment. Mounjaro (tirzepatide) works on two gut-hormone receptors, GIP and GLP-1, and slows gastric emptying — a process that can affect how the mouth handles saliva, stomach acid, and taste signals. The NHS medicines page for tirzepatide lists taste changes among the reported effects of this class of medicine, and if you have noticed something odd (metallic, bitter, or just different) you are not imagining it. Because Mounjaro is a prescription-only medicine, any concerns about how it is affecting you are worth discussing with the prescriber who oversees your treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The tirzepatide trials (including the SURMOUNT-1 study, which followed thousands of adults over 72 weeks and is the basis for Mounjaro's UK licence) were primarily designed to measure weight loss and metabolic outcomes. Taste disturbance was not a primary endpoint, but altered taste, dry mouth, and oral discomfort surfaced in participant reports and were captured in adverse-event data. GLP-1 receptor agonists as a class are associated with gastrointestinal effects, and the oral cavity is part of that system: GLP-1 receptors exist in saliva-producing glands and in the taste-bud cell network, which means activating them pharmacologically can genuinely shift how flavours register.
Tirzepatide's dual action (engaging both GLP-1 and GIP receptors) adds a second variable. GIP receptors are also expressed in tissues of the head and neck, and while the research on exactly how this contributes to taste changes in humans is still developing, the patient experience is consistent enough to take seriously. You can explore more about how these mechanisms interact on the tirzepatide overview page.
The practical upshot: a weird taste in the mouth on Mounjaro is biologically plausible and clinically recognised, and if you want a deeper look at what that experience involves, our page on Mounjaro taste in mouth covers the topic in full. It does not mean the medicine is harming you, but it warrants attention if it is severe, worsening, or accompanied by pain.
Timing matters here. Most people who notice a strange taste report it in one of two windows: the first two to three weeks after starting Mounjaro, and again for a short period after each dose increase. Both windows correspond to the body adjusting to a new level of receptor activation. Gastric emptying slows more noticeably at these points, which can push stomach acid higher, increase reflux, and alter the flavour environment in the mouth even without obvious heartburn.
Nausea (a common early effect detailed on the Mounjaro page) often accompanies this because both stem from the same gastric-slowing mechanism. If you notice a metallic or bitter note appearing shortly after your weekly injection and fading over a few days, that pattern fits what many people on tirzepatide describe. A quick check you can do in under a minute: note in your phone on injection day whether the taste is worse, the same, or improving week on week. A trend of steady improvement is reassuring; a trend of worsening is worth flagging to your prescriber.
People who also experience acid reflux or burping alongside the taste change will often find both ease together as GI symptoms settle. The Mounjaro SmPC on the eMC is the definitive reference for the full list of reported effects and their frequencies, and your prescriber or the Patient Information Leaflet in the box are the right sources for anything dose-specific.
There is no single fix, but several habits make the weird taste less intrusive. Hydration is the most consistent, dry mouth intensifies taste distortion, and drinking enough plain water throughout the day keeps saliva moving and dilutes any acid residue. Brushing teeth or rinsing with plain water roughly 30 minutes after eating (rather than immediately, to protect enamel) can also clear the taste faster.
Food choices matter too. Strong-flavoured foods (coffee, garlic, fatty or spiced dishes) can amplify an already-altered taste signal in the early weeks. Mild, protein-rich foods tend to be more palatable and also support the muscle preservation that matters during weight loss on tirzepatide. Some people find cold foods and drinks less likely to trigger the odd taste than hot ones, possibly because heat intensifies volatile flavour compounds.
If you are curious about the wider picture of oral effects people report while on tirzepatide, the Mounjaro mouth effects page covers this territory in more depth, including how different symptoms tend to relate to one another. For a specific look at the metallic end of the taste spectrum, this page on metallic taste and Mounjaro goes into greater detail.
A subtle, transient taste change does not need an urgent call. But certain patterns do. Tell your prescriber promptly if the taste change is worsening rather than improving after four to six weeks at a stable dose; if it is accompanied by significant mouth pain, soreness, or ulcers; or if you notice swallowing becoming difficult. These could point to something unrelated to tirzepatide that deserves assessment in its own right.
Separately, if you develop severe, persistent stomach pain that radiates to the back, with or without vomiting, stop using Mounjaro and get medical help immediately. This is the symptom pattern for acute pancreatitis, which the MHRA highlighted in its January 2026 Drug Safety Update for GLP-1 medicines, it is uncommon, but requires urgent attention. You can report any side effects directly at the MHRA's Yellow Card scheme.
For anything you are uncertain about between reviews, our clinical team is available seven days a week, you can find out how aftercare works via the contact page. If you are still in the process of exploring your options, and are also wondering whether combining treatments might be relevant to you, our page on stacking tirzepatide with retatrutide explains how that approach works and what to consider before discussing it with a prescriber. To get started, starting a free consultation is the right first step: a GPhC-registered prescriber reviews your details the same day and can talk through any concerns before treatment begins.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.